Opioid pharmacology and pharmacokinetics,biotransformation,pharmacodynamics,2000-2400 characters a side and 5 to 6 A4 sides of PDF text,behind the summary make small paragraph site where write about opioids and P450 cytochmrome (close relationship),sunergism and sntagonism of opiods and other drugs (sedatives-benzodiazepines,GABA-active substances,other opiates,cocaine,alcohol,barbiturates,Z-substances[zolpidem,stilnox,sanval],antidepressives,NSAID,paracetamol&caffeine-pain additives/supplementary analgesic, opioid antagonistic substances (pure antagonist - naloxone,naltrexone/peripheral(PAMA´s)-methylnaltrexon,naloxegol,naldemedine( obstipation cancel without analgesic antagonistic,partial agonists&agonist/antagonist-substances with dual effect-buprenorphine,pentazocine,nalbuphine(when administred to pure agonists addict, cuase strong "cold turkey" (withdrawal symptoms); crossing the hemtoencephalitic barrier and acting on receptors (mi,kappa,beta),long-term efect by taking high doses -> attenuation effects on receptors and more OUD(opiod use disorder) symptoms;
Opioid pharmacology and pharmacokinetics,biotransformation,pharmacodynamics,2000-2400 characters a side and 5 to 6 A4 sides of PDF text,behind the summary make small paragraph site where write about opioids and P450 cytochmrome (close relationship),sunergism and sntagonism of opiods and other drugs (sedatives-benzodiazepines,GABA-active substances,other opiates,cocaine,alcohol,barbiturates,Z-substances[zolpidem,stilnox,sanval],antidepressives,NSAID,paracetamol&caffeine-pain additives/supplementary analgesic, opioid antagonistic substances (pure antagonist - naloxone,naltrexone/peripheral(PAMA´s)-methylnaltrexon,naloxegol,naldemedine( obstipation cancel without analgesic antagonistic,partial agonists&agonist/antagonist-substances with dual effect-buprenorphine,pentazocine,nalbuphine(when administred to pure agonists addict, cuase strong "cold turkey" (withdrawal symptoms); crossing the hemtoencephalitic barrier and acting on receptors (mi,kappa,beta),long-term efect by taking high doses -> attenuation effects on receptors and more OUD(opiod use disorder) symptoms;
Created using ChatSlide
This overview covers key aspects of opioid pharmacology, including receptor effects and GPCR signaling related to analgesia and reward pathways. It contrasts pharmacokinetics and biotransformation, highlighting the significance of CYP450 pathways and pharmacogenetic variability. Additionally, it evaluates drug interactions, particularly with sedatives and alcohol, and discusses the implications of tolerance, withdrawal, and opioid use disorder (OUD), comparing various treatment approaches...